S. Oliver

406 total citations
20 papers, 313 citations indexed

About

S. Oliver is a scholar working on Pharmacology, Surgery and Oncology. According to data from OpenAlex, S. Oliver has authored 20 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Surgery and 4 papers in Oncology. Recurrent topics in S. Oliver's work include Cancer Treatment and Pharmacology (4 papers), Pharmacology and Obesity Treatment (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). S. Oliver is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Pharmacology and Obesity Treatment (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). S. Oliver collaborates with scholars based in United Kingdom, United States and Australia. S. Oliver's co-authors include Vibeke Hatorp, Keith Wesnes, Mark Wickens, Alan J. Stewart, Peter Buchan, Chris Ward, Andrew Wade, Chris Garratt, S Freestone and Richard Anziano and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Clinical Pharmacology and Headache The Journal of Head and Face Pain.

In The Last Decade

S. Oliver

20 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Oliver United Kingdom 10 65 65 58 47 40 20 313
Dietrich Türck Germany 8 61 0.9× 49 0.8× 45 0.8× 51 1.1× 38 0.9× 8 359
C H Gleiter Germany 8 49 0.8× 124 1.9× 77 1.3× 83 1.8× 56 1.4× 13 400
Klaus D. Raemsch Germany 6 74 1.1× 69 1.1× 53 0.9× 49 1.0× 54 1.4× 8 376
Prasarn Manitpisitkul United States 15 77 1.2× 51 0.8× 55 0.9× 77 1.6× 78 1.9× 23 434
Johan Wemer Netherlands 15 48 0.7× 49 0.8× 34 0.6× 102 2.2× 59 1.5× 34 460
R. Calvo Spain 14 65 1.0× 62 1.0× 32 0.6× 88 1.9× 65 1.6× 47 538
Niels Anders Klitgaard Denmark 13 80 1.2× 60 0.9× 39 0.7× 40 0.9× 48 1.2× 24 570
P. Anderson Sweden 13 45 0.7× 31 0.5× 37 0.6× 68 1.4× 70 1.8× 20 413
Zhen Zhao United States 12 30 0.5× 40 0.6× 93 1.6× 55 1.2× 102 2.5× 24 339
Maria Sunzel Sweden 11 26 0.4× 28 0.4× 89 1.5× 41 0.9× 56 1.4× 17 425

Countries citing papers authored by S. Oliver

Since Specialization
Citations

This map shows the geographic impact of S. Oliver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Oliver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Oliver more than expected).

Fields of papers citing papers by S. Oliver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Oliver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Oliver. The network helps show where S. Oliver may publish in the future.

Co-authorship network of co-authors of S. Oliver

This figure shows the co-authorship network connecting the top 25 collaborators of S. Oliver. A scholar is included among the top collaborators of S. Oliver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Oliver. S. Oliver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, Paul, Michael Gillen, James M. Ritter, et al.. (2016). Effects of Fostamatinib on the Pharmacokinetics of Oral Contraceptive, Warfarin, and the Statins Rosuvastatin and Simvastatin: Results From Phase I Clinical Studies. Drugs in R&D. 16(1). 93–107. 34 indexed citations
2.
Ranson, Malcolm, Richard H. Wilson, Joe M. O’Sullivan, et al.. (2010). Pharmacokinetic and tolerability profile of once-daily zibotentan (ZD4054) in Japanese and Caucasian patients with hormone-resistant prostate cancer. International Journal of Clinical Pharmacology and Therapeutics. 48(11). 708–717. 5 indexed citations
3.
4.
Tomkinson, Helen, Eva Engelhardt, S. Oliver, et al.. (2009). 1238 An open-label study of the pharmacokinetics, safety and tolerability of zibotentan (ZD4054) in subjects with mild, moderate, or severe renal impairment, or normal renal function. European Journal of Cancer Supplements. 7(2). 132–132. 2 indexed citations
5.
Saunders, M., Eric Van Cutsem, R. Wilson, et al.. (2007). Vandetanib with FOLFIRI in patients with advanced colorectal adenocarcinoma: an open-label, multicenter Phase I study. Journal of Clinical Oncology. 25(18_suppl). 4085–4085. 3 indexed citations
6.
Kemp, John P., et al.. (2007). 724 POSTER Metabolism of [14C]-ZD4054 in healthy volunteers. European Journal of Cancer Supplements. 5(4). 114–114. 6 indexed citations
7.
Tebbutt, Niall C., et al.. (2007). Vandetanib with mFOLFOX6 in advanced colorectal adenocarcinoma: An open-label, multicenter phase I study. Journal of Clinical Oncology. 25(18_suppl). 4095–4095. 4 indexed citations
8.
Hammett, Teresa A., S. Oliver, Parviz Ghahramani, et al.. (2005). The pharmacodynamic effect on cardiac repolarization of combination single dose ZD6474 and ondansetron in healthy subjects. Journal of Clinical Oncology. 23(16_suppl). 3197–3197. 2 indexed citations
9.
Smith, Ronald G., S. Oliver, Parviz Ghahramani, et al.. (2005). The effect of the CYP3A4 inhibitor, itraconazole, on the pharmacokinetics of ZD6474 in healthy subjects. Journal of Clinical Oncology. 23(16_suppl). 3124–3124. 5 indexed citations
10.
Buchan, Peter, Andrew Wade, Chris Ward, et al.. (2002). Frovatriptan: A Review of Drug‐Drug Interactions. Headache The Journal of Head and Face Pain. 42(s2). 63–73. 43 indexed citations
11.
Wesnes, Keith, et al.. (2000). Effects of sibutramine alone and with alcohol on cognitive function in healthy volunteers. British Journal of Clinical Pharmacology. 49(2). 110–117. 32 indexed citations
12.
Harness, Jane, et al.. (2000). Ziprasidone and the pharmacokinetics of a combined oral contraceptive. British Journal of Clinical Pharmacology. 49(S1). 49–56. 23 indexed citations
13.
Oliver, S.. (2000). The long-term safety and tolerability of ispaghula husk. The Journal of the Royal Society for the Promotion of Health. 120(2). 107–111. 14 indexed citations
14.
Purkins, Lynn, S. Oliver, & Susan Willavize. (1998). An open, controlled, crossover study on the effects of cimetidine on the steady-state pharmacokinetics of trovafloxacin. European Journal of Clinical Microbiology & Infectious Diseases. 17(6). 431–433. 1 indexed citations
15.
Hatorp, Vibeke, et al.. (1998). Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.. PubMed. 36(12). 636–41. 57 indexed citations
16.
Cockshott, I. D., et al.. (1997). THE EFFECT OF FOOD ON THE PHARMACOKINETICS OF THE BICALUTAMIDE (‘CASODEX’) ENANTIOMERS. Biopharmaceutics & Drug Disposition. 18(6). 499–507. 27 indexed citations
17.
Holt, Peter R., et al.. (1996). The effect of ziprasidone on steady-state pharmacokinetics of a combined oral contraceptive. European Psychiatry. 11. 419s–419s. 1 indexed citations
18.
Williams, Shirley, Keith Wesnes, S. Oliver, & Garth Rapeport. (1996). Absence of effect of sertraline on time-based sensitization of cognitive impairment with haloperidol.. PubMed. 57 Suppl 1. 7–11. 17 indexed citations
19.
Rayner, Brian, et al.. (1993). Inoculation of peritoneal dialysate fluid into blood culture bottles improves culture rates.. PubMed. 83(1). 42–3. 14 indexed citations
20.
Oliver, S., et al.. (1990). Pseudomonas septicaemia after endoscopic retrograde cholangiopancreatography--an unresolved problem.. PubMed. 77(10). 509–11. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dietrich Türck Breakdown of academic impact, for papers by C H Gleiter Breakdown of academic impact, for papers by Klaus D. Raemsch Breakdown of academic impact, for papers by Prasarn Manitpisitkul Breakdown of academic impact, for papers by Johan Wemer Breakdown of academic impact, for papers by R. Calvo Breakdown of academic impact, for papers by Niels Anders Klitgaard Breakdown of academic impact, for papers by P. Anderson Breakdown of academic impact, for papers by Zhen Zhao Breakdown of academic impact, for papers by Maria Sunzel
Rankless by CCL
2026